Pressroom: Press Releases

2013

Most Popular Ovarian Cancer Cell Lines Do Not Resemble Ovarian Cancer

Researchers from Memorial Sloan Kettering Cancer Center recently discovered that the most frequently used cancer cell lines in ovarian cancer research are not suitable models of ovarian cancer.

July 12, 2013
Combination of Drugs Produces Dramatic Tumor Responses in Advanced Melanoma Patients

The combination of the immunotherapy drug ipilimumab and the investigational antibody drug nivolumab led to long-lasting tumor shrinkage in more than half of patients with metastatic melanoma, according to results from a Phase I trial simultaneously published in The New England Journal of Medicine and presented at the 49th Annual Meeting of the American Society of Clinical Oncology.

June 2, 2013
New Therapy Shown To Improve Progression-Free Survival and Shrink Tumors in Rare Cancer for the First Time

The experimental drug selumetinib is the first targeted therapy to demonstrate significant clinical benefit for patients with metastatic uveal melanoma, according to new Memorial Sloan Kettering Cancer Center research presented at the 49th annual meeting of the American Society of Clinical Oncology.

June 1, 2013
Foundation Medicine and Memorial Sloan Kettering Cancer Center Announce Partnership to Advance Patient Care in Hematologic Cancers

Foundation Medicine and Memorial Sloan Kettering Cancer Center today announced a partnership that brings together clinical, genomic and computational expertise to advance patient care in hematologic cancers.

May 2, 2013
Large Genomic Study Identifies Endometrial Cancer Subtypes, Treatment Opportunities

Endometrial tumors can be reclassified into distinct subtypes based partly on their genomic makeup and may respond to targeted drugs already being tested in clinical trials, according to a large-scale genomic analysis led by researchers at Memorial Sloan Kettering Cancer Center and other centers within The Cancer Genome Atlas Research Network.

May 1, 2013
New Monoclonal Antibody Developed That Can Target Proteins Inside Cancer Cells

Scientists from Memorial Sloan Kettering Cancer Center and Eureka Therapeutics have collaborated to create the new human monoclonal antibody, which targets a protein associated with many types of cancer and is of great interest to cancer researchers.

March 13, 2013
Memorial Sloan Kettering Appoints Avice Meehan as Vice President of Communications and Chief Communications Officer

In this new expanded role, Avice Meehan will streamline communications across the Center and lead both Memorial Sloan Kettering’s Public Affairs and Marketing endeavors.

March 12, 2013
Memorial Sloan Kettering Announces New Appointments

Memorial Sloan Kettering Cancer Center announces the appointments of medical oncologist Anas Younes, surgical pathologist David S. Kimstra, surgeon Julio Garcia-Aguilar, and radiologist Wolfgang Weber.

March 5, 2013
Drug Shown to Reverse Radioiodine Resistance in Some Advanced Thyroid Cancers

The experimental drug selumetinib may allow some patients with advanced thyroid cancer to overcome resistance to radioiodine (RAI), the most effective therapy for the disease, according to new research from Memorial Sloan Kettering Cancer Center.

February 13, 2013
Westchester Medical Center Opens New Outpatient Oncology Center in Partnership with Memorial Sloan Kettering

Westchester Medical Center today announced the opening of its new 5,300-square-foot outpatient Infusion Center, ushering in a new partnership with Memorial Sloan Kettering Cancer Center, whose staff will provide outpatient cancer care and infusion services.

February 13, 2013
IBM Watson Hard At Work: New Breakthroughs Transform Quality Care for Patients

IBM, WellPoint, Inc., and Memorial Sloan Kettering Cancer Center today unveiled the first commercially developed Watson-based cognitive computing breakthroughs. These innovations stand alone to help transform the quality and speed of care delivered to patients through individualized, evidence-based medicine.

February 8, 2013
New Position Created to Streamline, Accelerate, and Expand Clinical Research at Memorial Sloan Kettering

Memorial Sloan Kettering Cancer Center has announced the appointment of medical oncologist Paul Sabbatini to the new position of Deputy Physician-in-Chief for Clinical Research.

January 17, 2013

2012

David M. Rubenstein Gives $10 Million to Launch Pancreatic Cancer Research Center at Memorial Sloan Kettering

A new pancreatic cancer research center has been created at Memorial Sloan Kettering Cancer Center (MSKCC). The ambitious initiative was established with an initial commitment of $10 million from MSKCC Board member David M. Rubenstein.

December 7, 2012
Medication Before and After Treatment Improves Overall Sexual Function in Men with Prostate Cancer

Prostate cancer patients who are prescribed oral erectile medication before and after radiation therapy have improved sexual function, according to a research team at Memorial Sloan Kettering Cancer Center.

October 29, 2012
Memorial Sloan Kettering Cancer Center Announces Appointment of New Physician-in-Chief

Internationally recognized physician-scientist José Baselga has been named Physician-in-Chief of Memorial Hospital. He joins Memorial Sloan Kettering from Massachusetts General Hospital.

September 5, 2012
Childhood Cancer Treatment Found to Pose Similar Risk for Breast Cancer as BRCA Mutations

New data reveals that women treated with radiation to the chest for childhood cancer have a high risk of developing breast cancer similar to that of women with BRCA1/2 mutations. The study, led by Memorial Sloan Kettering Cancer Center biostatistician Chaya Moskowitz, PhD, was presented today at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting.

June 4, 2012
Testing for Mutations Identified in Squamous Cell Lung Cancer Tumors Helps Personalize Treatment

Researchers from Memorial Sloan Kettering Cancer Center have begun testing for three new genetic targets and found that together they occur in approximately 50 percent of patients with squamous cell carcinomas of the lung, which affects 40,000 Americans each year. Initial findings of the research will be presented on June 4 at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting.

May 16, 2012
Memorial Sloan Kettering Commack Offers Free Mammograms to Eligible Women on Long Island

Women on Long Island who don’t have insurance or who are underinsured may be able to take advantage of free mammograms at Memorial Sloan Kettering Cancer Center Commack.

May 8, 2012
Memorial Sloan Kettering's Website Nominated for Webby Award

Memorial Sloan Kettering Cancer Center’s website has been nominated for The Webby Award, the most prestigious international award honoring excellence on the Internet. Selected from among nearly 10,000 total entries, the Center’s website is one of five nominated in the Health category.

April 12, 2012
Antibody Therapy Prevents Gastrointestinal Damage following Radiation Exposure in Mice

A new study offers the first evidence of a drug capable of preventing lethal damage to the gastrointestinal (GI) tract caused by exposure to high levels of ionizing radiation, such as those occurring during a nuclear incident.

April 4, 2012
Syndicate content